Advertisement

Cord Factor and Related Synthetic Trehalose Diesters

  • Edgar Lederer

Abstract

The term ‘cord factor’ designates glycolipids produced by Mycobacteria, Nocardiae, Corynebacteriae, and strains of Arthrobacter and Brevibacterium; they are 6,6′-diesters of α, α-D-trehalose [48] (Fig. 1) (for reviews see [4, 5, 19, 34, 35, 36, 52])1.

Keywords

Antitumour Activity Mycolic Acid Cancer Immunol Intralesional Injection Muramyl Dipeptide 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Adam, A., Ciorbaru, R., Petit, J-F., Lederer, E.: Isolation and properties of a macromolecular, water soluble immuno-adjuvant fraction from the cell wall of M. smegmatis. Proc. Natl. Acad. Sci. USA 69, 851 (1972)PubMedCrossRefGoogle Scholar
  2. 2.
    Adam, A., Senn, M., Vilkas, E., Lederer, E.: Spectrométrie de masse de glycolipides. 2. Diesters de tréhalose naturels et synthétiques. Eur. J. Biochem. 2, 460 (1967)PubMedCrossRefGoogle Scholar
  3. 3.
    Artman, M., Bekierkunst, A., Goldenberg, I.: Tissue metabolism in infection: Biochemical changes in mice treated with cord factor. Arch. Biochem. Biophys. 105, 80 (1964)Google Scholar
  4. 4.
    Asselineau, C., Asselineau, J.: Trehalose containing glycolipids. Prog. Chem. Fats Other Lipids 16, 59 (1978)PubMedCrossRefGoogle Scholar
  5. 5.
    Asselineau, C., Asselineau, J.: Lipides spécifiques des mycobactéries. Ann. Microbiol. (Paris) 129 A, 49 (1978)Google Scholar
  6. 6.
    Azuma, I., Ribi, E. E., Meyer, T. J., Zbar, B.: Biologically active components from mycobacterial cell walls. I. Isolation and composition of cell wall skeleton and components P3. J. Natl. Cancer Inst. 52, 95 (1974)PubMedGoogle Scholar
  7. 7.
    Azuma, I., Yamawaki, N., Ogura, T., Yoshimoto, T., Toruzen, R., Hirao, F., Yamamura, Y.: Antitumour activity of BCG cell-wall skeleton and related materials. Gann Monograph on Cancer Res. 21, 73 (1978)Google Scholar
  8. 8.
    Bekierkunst, A.: Acute granulomatous response produced in mice by trehalose-6,6′-dimycolate. J. Bacteriol. 96, 958 (1968)PubMedGoogle Scholar
  9. 9.
    Bekierkunst, A.: Immunotherapy and vaccination against cancer with non-living BCG and cord factor (trehalose-6,6′-dimycolate). Int. J. Cancer 16, 442 (1975)PubMedCrossRefGoogle Scholar
  10. 10.
    Bekierkunst, A.: Immunotherapy of cancer with non-living Mycobacteria and cord factor (trehalose-6,6′-dimycolate) in aqueous medium. J. Natl. Cancer Inst. 57, 963 (1976)PubMedGoogle Scholar
  11. 11.
    Bekierkunst, A., Levij, I. S., Yarkoni, E., Vilkas, E., Lederer, E.: Suppression of urethan-induced lung adenomas in mice treated with trehalose-6,6′-dimycolate (cord factor) and living Bacillus Calmette Guerin. Science 174, 1240 (1971)PubMedCrossRefGoogle Scholar
  12. 12.
    Bekierkunst, A., Wang, L., Toubiana, R., Lederer, E.: Immunotherapy of cancer with non-living BCG and fractions derived from mycobacteria: role of cord factor (trehalose-6,6′-dimycolate) in tumour regression. Infect. Immun. 10, 1044 (1974)PubMedGoogle Scholar
  13. 13.
    Colbert, J-C.: Sugar esters preparation and applications. Chemical Technology Review, n° 32, Noyes Data Corp., Park Ridge, N.J., 310 p. 1974Google Scholar
  14. 14.
    Bloch, H.: Studies on the virulence of tubercle bacilli. Isolation and biological properties of a constituent of virulent organisms. J. Exp. Med. 91, 197 (1950)PubMedCrossRefGoogle Scholar
  15. 15.
    Brennan, P. J., Goren, M. B.: Mycobacterial glycolipids as bacterial antigens. Biochem. Soc. Trans. 5, 1687 (1977)PubMedGoogle Scholar
  16. 15a.
    Clark, I. A.: Protection of mice against Babesia microti with cord factor, COAM, zymosan, glucan, Salmonella and Listeria. Parasite Immunology (in press, 1979)Google Scholar
  17. 16.
    Durand, E., Welby, M., Laneelle, G., Tocanne, J-F.: Phase behaviour of cord factor and related glycolipid toxins. A monolayer study. Eur. J. Biochem. 93, 103 (1978)CrossRefGoogle Scholar
  18. 17.
    Ellouz, F., Adam, A., Ciorbaru, R., Lederer, E.: Minimal structural requirements for adjuvant activity of bacterial peptidoglycan derivatives. Biochem. Biophys. Res. Commun. 59, 1317 (1974)PubMedCrossRefGoogle Scholar
  19. 18.
    Etemadi, A. H.: Structure, biogenesis and phylogenetic interest of mycolic acids. Expos. Annu. Biochim. Med. 28, 77 (1967)PubMedGoogle Scholar
  20. 19.
    Goren, M. B.: Mycobacterial lipids: selected topics. Bacteriol. Rev. 36, 33 (1972)PubMedGoogle Scholar
  21. 20.
    Goren, M. B., Das, B. C., Brokl, O.: Sulfatide III of Mycobacterium tuberculosis strain H37Rv. Nouveau J. Chimie 2, 379 (1978)Google Scholar
  22. 21.
    Granger, D. L., Yamamoto, K., Ribi, E. E.: Delayed hypersensitivity and granulomatous response after immunization with protein antigens associated with a mycobacterial glycolipid and oil droplets. J. Immunol. 116, 482 (1976)PubMedGoogle Scholar
  23. 22.
    Ioneda, T., Lederer, E., Rozanis, J.: Sur la structure de diesters de tréhalose (cord factors) produits par Nocardia asteroides et N. rhodococcus. Chem. Phys. Lipids 4, 375 (1970)CrossRefGoogle Scholar
  24. 23.
    Ioneda, T., Lenz, M., Pudles, J.: Chemical constitution of a glycolipid from C. diphtheriae P. W. 8. Biochem. Biophys. Res. Commun. 13, 110 (1963)CrossRefGoogle Scholar
  25. 24.
    Kato, M.: Preparation of an aqueous suspension of cord factor. Am. Rev. Respir. Dis. 95, 553 (1967)Google Scholar
  26. 25.
    Kato, M.: Studies of a biochemical lesion in experimental tuberculosis in mice. XI. Mitochondrial swelling induced by cord factor in vitro. Am. Rev. Respir. Dis. 100, 47 (1969)PubMedGoogle Scholar
  27. 26.
    Kato, M.: Site II- specific inhibition of Mitochondrial oxidative phosphorylation by trehalose-6,6′-dimycolate (cord factor) of Mycobacterium tuberculosis. Arch. Biochem. Biophys. 140, 379 (1970)PubMedCrossRefGoogle Scholar
  28. 27.
    Kato, M.: Action of a toxic glycolipid of Corynebacterium diphtheriae on mitochondrial structure and function. J. Bacteriol. 101, 709 (1970)PubMedGoogle Scholar
  29. 28.
    Kato, M.: Site of action of the cord factor of Corynebacterium diphtheriae in mitochondria. J. Bacteriol. 107, 746 (1971)PubMedGoogle Scholar
  30. 29.
    Kato, M., Asselineau, J.: Chemical structure and biochemical activity of cord factors analogs 6,6′-dimycoloyl sucrose and methyl 6-mycoloyl-α-D-glucoside. Eur. J. Biochem. 22, 364 (1971)PubMedCrossRefGoogle Scholar
  31. 30.
    Kato, M., Tamura, T., Silve, G., Asselineau, J.: Chemical structure and biochemical activity of cord factors analogs. A comparative study of esters of methyl glucoside and non-hydroxylated fatty acids. Eur. J. Biochem. 87, 497 (1978)PubMedCrossRefGoogle Scholar
  32. 31.
    Kelly, M. T.: Plasma-Dependent Chemotaxis of Macrophages towards BCG cell walls and the Mycobacterial Glycolipid P3. Infect. Immun. 15, 180 (1977)PubMedGoogle Scholar
  33. 32.
    Laneelle, M. A., Asselineau, J.: Caractérisation de glycolipides dans une souche de Nocardia brasiliensis. FEBS Lett. 7, 64 (1970)CrossRefGoogle Scholar
  34. 33.
    Leclerc, C., Lamensans, A., Chedid, L., Drapier, J-C., Petit, J-F., Wietzerbin, J., Lederer, E.: Nonspecific immunoprevention of L1210 Leukemia by cord factor (6–6′-dimycolate of trehalose) administered in a metabolizable oil. Cancer Immunol. Immunother. 1, 227 (1976)CrossRefGoogle Scholar
  35. 34.
    Lederer, E.: The mycobacterial cell wall. Pure Applied Chemistry 25, 135 (1971)CrossRefGoogle Scholar
  36. 35.
    Lederer, E.: Cord factor and related trehalose esters. Chem. Phys. Lipids 16, 91 (1976)PubMedCrossRefGoogle Scholar
  37. 36.
    Lederer, E.: Natural and synthetic immunostimulants related to the mycobacterial cell wall. In: Medicinal chemistry V, p. 257. Amsterdam: Elsevier Scientific Publishing Company 1977Google Scholar
  38. 37.
    McLaughlin, C. A., Parker, R., Hadlow, W. J., Toubiana, R., Ribi, E. E.: Moieties of mycobacterial mycolates required for inducing granulomatous reactions. Cell. Immunol. 38, 14 (1978)PubMedCrossRefGoogle Scholar
  39. 38.
    McLaughlin, C. A., Ribi, E. E., Goren, M. B., Toubiana, R.: Tumour regression induced by defined microbial components in an oil in water emulsion is mediated through their binding to oil droplets. Cancer Immunol. Immunother. 4, 109 (1978)Google Scholar
  40. 39.
    McLaughlin, C. A., Strain, S. M., Bickel, M. D., Goren, M. B., Azuma, I., Mimer, K., Cantrell, J. L., Ribi, E. E.: Regression of line-10 hepatocellular carcinomas following treatment with water-soluble, microbial extracts combined with trehalose or arabinose mycolates. Cancer Immunol. Immunother. 4, 61 (1978)Google Scholar
  41. 40.
    Mahmoud, A. A. F., Civil, R. H. D., Lederer, E., Chedid, L.: Enhancement of resistance against a multicellular Helminth (Schistosoma mansoni) by cord factor (CF). Clin. Res. 25, 380A (1977)Google Scholar
  42. 41.
    Maurice, M. T., Vacheron, M. J. Michel, G.: Isolement d’acides nocardiques de plusieurs especes de Nocardia. Chem. Phys. Lipids 7, 9 (1971)PubMedCrossRefGoogle Scholar
  43. 42.
    Meyer, J. T., Ribi, E. E., Azuma, I., Zbar, B.: Biologically active components from Mycobacterial cell walls. II. Suppression and regression of strain-2 guinea pig hepatoma. J. Natl. Cancer Inst. 52, 103 (1974)PubMedGoogle Scholar
  44. 43.
    Meyer, J. T., Ribi, E. E., Azuma, I.: Biologically active components from mycobacterial cell walls. V. Granuloma formation in mouse lungs and guinea pig skin. Cell. Immunol. 16, 11 (1975)PubMedCrossRefGoogle Scholar
  45. 44.
    Michel, G., Bordet, C.: Cell wall of Nocardiae, in: The biology of the nocardiae, Goodfellow, M., Brownell, S. H., Serrano, J. A., eds. p. 141. New York: Academic Press 1976Google Scholar
  46. 45.
    Mompon, B., Federici, C., Toubiana, R., Lederer, E.: Isolation and structural determination of a ‘cord factor’ (trehalose 6,6′-dimycolate) from Mycobacterium smegmatis. Chem. Phys. Lipids 21, 97 (1978)PubMedCrossRefGoogle Scholar
  47. 46.
    Nigam, V. N., Brailovsky, C. A., Chopra, C.: Maltose tetra-palmitate, a non-toxic immunopotentiatior with antitumour activity. Cancer Res. 38, 3315 (1978)PubMedGoogle Scholar
  48. 47.
    Nishikawa, Y., Yoshimoto, K., Okabe, M., Fukuoka, F.: Chemical and biochemical studies on carbohydrate esters. III. Antitumour activity of unsaturated fatty acids and their ester derivatives against Ascites Carcinoma. Chem. Pharm. Bull. (Tokyo) 24, 756 (1976)Google Scholar
  49. 48.
    Noll, E., Bloch, H., Asselineau, J., Lederer, E.: The chemical structure of the cord factor of M yobacterium tuberculosis. Biochim. Biophys. Acta 20, 299 (1956)PubMedCrossRefGoogle Scholar
  50. 49.
    Ofek, I., Bekierkunst, A.: Chemotactic responses of leukocytes to cord factor (trehalose-6,6′-dimycolate) J. Natl. Cancer Inst. 57, 1379 (1976)PubMedGoogle Scholar
  51. 49a.
    Olds, G. R., Chedid, L., Lederer, E., Mahmoud, A. F.: Induction of resistance to Schistosoma mansoni by natural cord factor and synthetic lower homologs. J. Inf. Dis. (in press, 1979)Google Scholar
  52. 50.
    Parant, M., Prant, F., Chedid, L., Drapier, J.-C., Petit, J-F., Wietzerbirn, J., Lederer, E.: Enhancement of non-specific immunity to bacterial infection by cord factor (6.6′-trehalose dimycolate) J. Infect. Dis. 135, 771 (1977)PubMedCrossRefGoogle Scholar
  53. 51.
    Parant, M., Audibert, F., Parant, F., Chedid, L., Soler, E., Polonsky, J., Lederer, E.: Non-specific immunostimulant activities of synthetic trehalose-6,6′-diesters (lower homologs of cord factor). Infect. Immun. 20, 12 (1978)PubMedGoogle Scholar
  54. 52.
    Petit, J-F., Lederer, E.: Structure and immunostimulant properties of myobacterial cell walls. Symposia of the Society for General Microbiology Number XXVIII. Relations between structure and function in the Prokaryotic cell. p. 177. Cambridge: University Press 1978Google Scholar
  55. 53.
    Polonsky, J., Soler, E., Toubiana, R., Takayama, K., Raju, M. S., Wenkert, E.: A carbon-13 nuclear magnetic resonance spectral analysis of cord factors and related substances. Nouveau J. Chimie 2, 4 (1978)Google Scholar
  56. 54.
    Polonsky, J., Soler, E., Varenne, J.: Sur la synthese du cord factor et de ses analogues. Carbohydr. Res. 65, 295 (1978)CrossRefGoogle Scholar
  57. 55.
    Pommier, M. T., Michel, G.: Glycolipides de Nocardiae. Isolement et caractérisation de monocardomycolates et de dinocardomycolates de trehalose dans une souche de Nocardiae caviae. Chem. Phys. Lipids (1979) in pressGoogle Scholar
  58. 56.
    Prome, J. C., Lacave, C., Ahibo-Coffy, A. Savagnac, A.: Séparation et étude structurale des espèces moléculaires de monomycolates et de dimycolates de α-D-tréhalose présents chez Mycobacterium phlei. Eur. J. Biochem. 63, 543 (1976)PubMedCrossRefGoogle Scholar
  59. 57.
    Quereshi, N., Takayama, K.: Characterization of the purified components of a new homologous series of α-mycolic acids from Mycobacterium tuberculosis H37 Ra. J. Biol. Chem. 253, 5411 (1978)Google Scholar
  60. 58.
    Rapp, H. J., Yarkoni, E.; Ruco, L., Hunter, J. T.: Immunotherapy of a guinea pig hepatoma with vaccines containing mycobacterial fractions. Comparison of cell walls and trehalose 6,6′-dimycolate. Cancer Immunol. Immunother. 3, 179 (1978)CrossRefGoogle Scholar
  61. 59.
    Ribi, E. E., Anacker, R. L., Barclay, W. R., Brehmer, W., Harris, S. C., Leif, W. R., Simmons, J.: Efficacy of mycobacterial cell walls as a vaccine against airborne tuberculosis in the rhesus monkey. J. Infect. Dis. 123, 527 (1971)PubMedCrossRefGoogle Scholar
  62. 60.
    Ribi, E. E., Granger, D. L., Milner, K. C., Strain, S. M.: Tumour regression caused by endotoxins and mycobacterial fractions. J. Natl. Cancer Inst. 55, 1253 (1975)PubMedGoogle Scholar
  63. 61.
    Ribi, E., Meyer, T. J., Azuma, I., Parker, R., Brehmer, W.: Biologically active components from Mycobacterial cell walls. IV. Protection of mice against aerosol infection with virulent M yobacterium tuberculosis. Cell. Immunol. 16, 1 (1975)PubMedCrossRefGoogle Scholar
  64. 62.
    Ribi, E. E., Milner, K. C., Granger, D. L., Kelly, M. T., Yamamoto, K., Brehmer, W., Parker, R., Smith, R. F., Strain, S. M.: Immunotherapy with non-viable microbial components. Ann. NY Acad. Sci 277, 228 (1976)PubMedCrossRefGoogle Scholar
  65. 63.
    Ribi, E.E., Parker, R., Milner, K.: Microparticulate gel chromatography accelerated by centrifugal force and pressure. Methods. Biochem. Anal. 22, 355 (1974)PubMedCrossRefGoogle Scholar
  66. 64.
    Ribi, E. E., Takayama, K., Milner, K., Gray, G. R., Goren, M. B., Parker, R., McLaughlin, C., Kelly, M.: Regression of tumours by an endotoxin combined with trehalose mycolates of differing structure. Cancer Immunol Immunother. 1, 265 (1976)CrossRefGoogle Scholar
  67. 65.
    Ribi, E. E., Toubiana, R., Strain, S. M., Milner, K. C., McLaughlin, C., Cantrell, J., Azuma, I., Das, B. C., Parker, R.: Further studies on the structural requirements of agents for immunotherapy of the guinea pig line-10 tumour. Cancer Immunol Immunother. 3, 171 (1978)CrossRefGoogle Scholar
  68. 66.
    Saito, R. Nagao, S., Takamoto, M., Sugiyama, K., Takamoto, M., Sugiyama, K., Tanaka, A.: Adjuvanticity (immunity-inducing property) of cord factor in mice and rats. Infect. Immun. 16, 725 (1977)PubMedGoogle Scholar
  69. 67.
    Saito, R., Tanaka, A., Sugiyama, K., Azuma, I., Yamamura, Y., Kato, M., Goren, M. B.: Adjuvant effect of cord factor, a mycobacterial lipid. Infect. Immun. 13, 776 (1976)PubMedGoogle Scholar
  70. 68.
    Saito, R., Tanaka, A., Sugiyama, K., Kato, M.: Cord factor not toxic in rat. Am. Rev. Respir. Dis. 112, 578 (1975)PubMedGoogle Scholar
  71. 69.
    Shankaran, R., Venkitasubramanian, T. A.: Effect of Cord factor on carbohydrate metabolism in mice. Am. Rev. Respir. Dis. 101, 401 (1970)PubMedGoogle Scholar
  72. 70.
    Steck, P. A., Schwartz, B. A., Rosendahl, M. S., Gray, G. R.: Mycolic acids. A reinvestigation. J. Biol. Chem. 253, 5626 (1978)Google Scholar
  73. 71.
    Strain, S. M., Toubiana, R., Ribi, E. E., Parker, R.: Separation of the Mixture of Trehalose 6,6′-dimycolate, the mycobacterial glycolipid fraction, “P3”. Biochem. Biophys. Res. Commun. 77, 449 (1977)PubMedCrossRefGoogle Scholar
  74. 72.
    Suter, E., Kirsanow, E. M.: Hyperreactivity to endotoxin in mice infected with mycobacteria. Induction and elicitation of the reactions. Immunology 4, 354 (1961)PubMedGoogle Scholar
  75. 73.
    Tocanne, J-F.: Sur une nouvelle voie de synthèse du cord factor, glycolipide toxique de Mycobacterium tuberculosis (esters du trahelose et d’acides gras α-ramifiés, β-hydroxylés). Carbohydr. Res. 44, 301 (1975)PubMedCrossRefGoogle Scholar
  76. 74.
    Toubiana, R., Das, B. C., Defaye, J., Mompon, B., Toubiana, M. J.: Etude du cord factor et de ses analogues. Partie III. Synthèse du cord factor (6,6′-di-Oemycoloyl-α, α-trehalose). Carbohydr. Res. 44, 308 (1975)PubMedCrossRefGoogle Scholar
  77. 75.
    Toubiana, R., Ribi, E. E., McLaughlin, C., Strain, S. M.: The effect of synthetic and naturally occurring trehalose fatty acid esters in tumour regression. Cancer Immunol Immunother. 2, 189 (1977)CrossRefGoogle Scholar
  78. 76.
    Toubiana, R., Pizza, C., Chapleur, Y., Castro, B.: Etude du cord factor et de ses analogues. Partie IV: préparation du di-0-corynomycoloyl-6,6′-α, α-trehalose par l’interméditaire du bisel d’alkyloxytris (dimethylmino)phosphonium (ATDP). J. Carbohydr. Nucleosides Nucleotides 5, 127 (1978)Google Scholar
  79. 77.
    Toubiana, R., Toubiana, M.-J.: Synthese d’analogues du cord factor. Partie II. Préparation de 6,6′-dipalmitate de tréhalose par transestérification. Biochimie 55, 575 (1973)PubMedCrossRefGoogle Scholar
  80. 78.
    White, R. G., Bernstock, L., Johns, R. G., Lederer, E.: The influence of components of Myobacterium tuberculosis and other mycobacteria upon antibody production to ovalbumin. Immunology 1, 54 (1958)PubMedGoogle Scholar
  81. 79.
    Yarkoni, E., Bekierkunst, A.: Nonspecific resistance against infection with Salmonella typhi and S.typhimurium induced in mice by cord factor (trehalose 6,6′-dimycolate) and its analogues. Infect. Immun. 14, 1125 (1976)PubMedGoogle Scholar
  82. 80.
    Yarkoni, E., Meltzer, M. S., Rapp, H. J.: Failure of trehalose-6,6′-dimycolate (P3 or cord factor) to enhance endotoxin lethality in mice. Infect. Immun. 14, 1375 (1976)PubMedGoogle Scholar
  83. 81.
    Yarkoni, E., Meltzer, M. S., Rapp, H. J.: Tumour regression after intralesional injection of emulsified trehalose 6,6′-dimycolate (cord factor): efficacy increases with oil concentration. Int. J. Cancer 19, 818 (1977)PubMedCrossRefGoogle Scholar
  84. 82.
    Yarkoni, E., Rapp, H. J.: Granuloma formation in lungs of mice after intravenous administration of emulsified trehalose-6,6′-dimycolate (cord factor): reaction intensity depends on size distribution of the oil droplets. Infect. Immun. 18, 552 (1977)PubMedGoogle Scholar
  85. 83.
    Yarkoni, E., Rapp, H. J.: Toxicity of emulsified trehalose-6,6′-dimycolate (cord factor) in mice depends on the size distribution of the mineral oil droplets. Infect. Immun. 20, 856 (1978)PubMedGoogle Scholar
  86. 83a.
    Yarkoni, E., Rapp, H. J.: Influence of oil and tween concentration on enhanced endotoxin lethality in mice pretreated with emulsified trehalose 6,6′-dimycolate (cord factor). Infect. Immun. 24, 571 (1979)PubMedGoogle Scholar
  87. 84.
    Yarkoni, E., Rapp, H. J., Polonsky, J., Lederer, E.: Immunotherapy with an intralesionally administered synthetic cord factor analogue. Int. J. Cancer 22, 564 (1978)PubMedCrossRefGoogle Scholar
  88. 84a.
    Yarkoni, E., Rapp, H. J., Polonsky, J., Varenne, J., Lederer, E.: Regression of a murine fibrosarcoma after intralesional injection of a synthetic C39 glycolipid related to cord factor. Infect. Immun. (in press, 1979)Google Scholar
  89. 85.
    Yarkoni, E., Wang, L., Bekierkunst, A.: Stimulation of macrophages by cord factor and by heat-killed and living BCG. Infect. Immun. 16, 1 (1977)PubMedGoogle Scholar
  90. 86.
    Zbar, B., Ribi, E. E., Meyer, T., Azuma, I., Rapp, H. J.: Immunotherapy of cancer: regression of established intradermal tumours after intralesional injection of mycobacterial cell walls attached to oil droplets. J. Natl. Cancer Inst. 52, 1571 (1974)PubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1980

Authors and Affiliations

  • Edgar Lederer
    • 1
    • 2
  1. 1.Laboratoire de BiochimieC.N.R.S.Gif-sur-YvetteFrance
  2. 2.Institut de BiochimieUniversité de Paris-SudOrsayFrance

Personalised recommendations